Return On Equity in % of Arbutus Biopharma Corp from Q3 2014 to Q3 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Arbutus Biopharma Corp quarterly and annual Return On Equity history and change rate from Q3 2014 to Q3 2025.
  • Arbutus Biopharma Corp Return On Equity for the quarter ending 30 Sep 2025 was -50%, a 26% increase year-over-year.
  • Arbutus Biopharma Corp annual Return On Equity for 2024 was -63%, a 9.6% decline from 2023.
  • Arbutus Biopharma Corp annual Return On Equity for 2023 was -58%, a 25% decline from 2022.
  • Arbutus Biopharma Corp annual Return On Equity for 2022 was -46%, a 22% increase from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Arbutus Biopharma Corp Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -50% +18% +26% 01 Jul 2025 30 Sep 2025
Q2 2025 -59% +7.4% +11% 01 Apr 2025 30 Jun 2025
Q1 2025 -75% -13% -20% 01 Jan 2025 31 Mar 2025
Q4 2024 -63% -5.6% -9.6% 01 Oct 2024 31 Dec 2024
Q3 2024 -68% -12% -21% 01 Jul 2024 30 Sep 2024
Q2 2024 -67% -15% -28% 01 Apr 2024 30 Jun 2024
Q1 2024 -63% -14% -30% 01 Jan 2024 31 Mar 2024
Q4 2023 -58% -12% -25% 01 Oct 2023 31 Dec 2023
Q3 2023 -56% -13% -30% 01 Jul 2023 30 Sep 2023
Q2 2023 -52% -6.5% -14% 01 Apr 2023 30 Jun 2023
Q1 2023 -48% +5.1% +9.5% 01 Jan 2023 31 Mar 2023
Q4 2022 -46% +13% +22% 01 Oct 2022 31 Dec 2022
Q3 2022 -43% +21% +33% 01 Jul 2022 30 Sep 2022
Q2 2022 -46% +24% +34% 01 Apr 2022 30 Jun 2022
Q1 2022 -53% +17% +24% 01 Jan 2022 31 Mar 2022
Q4 2021 -59% +16% +21% 01 Oct 2021 31 Dec 2021
Q3 2021 -64% +28% +30% 01 Jul 2021 30 Sep 2021
Q2 2021 -69% +114% +62% 01 Apr 2021 30 Jun 2021
Q1 2021 -70% +77% +52% 01 Jan 2021 31 Mar 2021
Q4 2020 -75% +47% +38% 01 Oct 2020 31 Dec 2020
Q3 2020 -92% +1.2% +1.3% 01 Jul 2020 30 Sep 2020
Q2 2020 -183% -136% -290% 01 Apr 2020 30 Jun 2020
Q1 2020 -146% -116% -386% 01 Jan 2020 31 Mar 2020
Q4 2019 -122% -97% -375% 01 Oct 2019 31 Dec 2019
Q3 2019 -94% -59% -172% 01 Jul 2019 30 Sep 2019
Q2 2019 -47% -17% -56% 01 Apr 2019 30 Jun 2019
Q1 2019 -30% +14% +31% 01 Jan 2019 31 Mar 2019
Q4 2018 -26% +21% +45% 01 Oct 2018 31 Dec 2018
Q3 2018 -34% +111% +76% 01 Jul 2018 30 Sep 2018
Q2 2018 -30% +82% +73% 01 Apr 2018 30 Jun 2018
Q1 2018 -44% +81% +65% 01 Jan 2018 31 Mar 2018
Q4 2017 -47% +49% +51% 01 Oct 2017 31 Dec 2017
Q3 2017 -145% -110% -312% 01 Jul 2017 30 Sep 2017
Q2 2017 -112% -77% -221% 01 Apr 2017 30 Jun 2017
Q1 2017 -125% -113% -969% 01 Jan 2017 31 Mar 2017
Q4 2016 -97% -86% -803% 01 Oct 2016 31 Dec 2016
Q3 2016 -35% -22% -160% 01 Jul 2016 30 Sep 2016
Q2 2016 -35% -23% -185% 01 Apr 2016 30 Jun 2016
Q1 2016 -12% +3.2% +22% 01 Jan 2016 31 Mar 2016
Q4 2015 -11% +29% +73% 01 Oct 2015 31 Dec 2015
Q3 2015 -14% +25% +65% 01 Jul 2015 30 Sep 2015
Q2 2015 -12% 01 Apr 2015 30 Jun 2015
Q1 2015 -15% 01 Jan 2015 31 Mar 2015
Q4 2014 -39% 01 Oct 2014 31 Dec 2014
Q3 2014 -39% 01 Jul 2014 30 Sep 2014

Arbutus Biopharma Corp Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -63% -5.6% -9.6% 01 Jan 2024 31 Dec 2024
2023 -58% -12% -25% 01 Jan 2023 31 Dec 2023
2022 -46% +13% +22% 01 Jan 2022 31 Dec 2022
2021 -59% +16% +21% 01 Jan 2021 31 Dec 2021
2020 -75% +47% +38% 01 Jan 2020 31 Dec 2020
2019 -122% -97% -375% 01 Jan 2019 31 Dec 2019
2018 -26% +21% +45% 01 Jan 2018 31 Dec 2018
2017 -47% +49% +51% 01 Jan 2017 31 Dec 2017
2016 -97% -86% -780% 01 Jan 2016 31 Dec 2016
2015 -11% +28% +72% 01 Jan 2015 31 Dec 2015
2014 -39% 01 Jan 2014 31 Dec 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.